Matt Kaeberlein is the CEO of OptiSpan and a scientist specializing in aging research aimed at extending healthspan and lifespan in humans and companion animals. He critically evaluates clinical research and advocates for responsible development of health products, particularly for dogs. Kaeberlein engages a broad audience through his public commentary and expertise in aging biology.

‌